Your browser doesn't support javascript.
loading
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era.
Blaker, Yngvild Nuvin; Spetalen, Signe; Brodtkorb, Marianne; Lingjaerde, Ole Christian; Beiske, Klaus; Østenstad, Bjørn; Sander, Birgitta; Wahlin, Björn Engelbrekt; Melen, Christopher Michael; Myklebust, June Helen; Holte, Harald; Delabie, Jan; Smeland, Erlend Bremertun.
Afiliación
  • Blaker YN; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway. ynblak@rr-research.no.
  • Spetalen S; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. ynblak@rr-research.no.
  • Brodtkorb M; Department of Pathology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Oslo, Norway.
  • Lingjaerde OC; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Beiske K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Østenstad B; Department of Oncology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Oslo, Norway.
  • Sander B; Section for Biomedical Informatics, Department of Computer Science, University of Oslo, Oslo, Norway.
  • Wahlin BE; Department of Pathology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Oslo, Norway.
  • Melen CM; Department of Oncology, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Oslo, Norway.
  • Myklebust JH; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Holte H; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet and Haematology Centre, Karolinska University Hospital, Stockholm, Sweden.
  • Delabie J; Division of Haematology, Department of Medicine at Huddinge, Karolinska Institutet and Haematology Centre, Karolinska University Hospital, Stockholm, Sweden.
  • Smeland EB; Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Br J Haematol ; 175(1): 102-14, 2016 10.
Article en En | MEDLINE | ID: mdl-27341313
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transformación Celular Neoplásica / Linfoma Folicular / Microambiente Tumoral Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2016 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transformación Celular Neoplásica / Linfoma Folicular / Microambiente Tumoral Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2016 Tipo del documento: Article País de afiliación: Noruega